Literature DB >> 18500384

Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells.

Ran Wang1, Hong Qing, Xiao-Qian Liu, Xiao-Lin Zheng, Yu-Lin Deng.   

Abstract

OBJECTIVE: The selective loss of dopaminergic neurons in Parkinson's disease is suspected to correlate with the increase of cellular iron, which may be involved in the pathogenesis of PD by promotion of oxidative stress. This research investigated dopamine-induced oxidative stress toxicity contributed by iron and the production of dopamine-derived neurotoxins in dopaminergic SH-SY5Y cells.
METHODS: After the SH-SY5Y cells were pre-incubated with dopamine and Fe2+ for 24 h, the cell viability, hydroxyl radical, melondialdehyde, cell apoptosis, and catechol isoquinolines were measured by lactate dehydrogenase assay, salicylic acid trapping method, thiobarbuteric acid assay, Hoechst 33258 staining and HPLC-electrochemical detection (HPLC-ECD), respectively.
RESULTS: (1) Optimal dopamine (150 micromol/L) and Fe2+ (40 or 80 micromol/L) significantly increased the concentrations of hydroxy radicals and melondialdehyde in SH-SY5Y cells. (2) Induction with dopamine alone or dopamine and Fe2+ (dopamine/Fe2+) caused cell apoptosis. (3) Compared with untreated cells, the catechol isoquinolines, salsolinol and N-methyl-salsolinol in dopamine/Fe2+-induced cells were detected in increasing amounts.
CONCLUSION: Due to dopamine/Fe2+-induced oxidative stress similar to the state in the parkinsonian substantia nigra neurons, dopamine and Fe2+ impaired SH-SY5Y cells could be used as the cell oxidative stress model of Parkinson's disease. The catechol isoquinolines detected in cells may be involved in the pathogenesis of Parkinson's disease as potential neurotoxins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500384      PMCID: PMC5552540          DOI: 10.1007/s12264-008-1214-z

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  25 in total

1.  Tetrahydroisoquinoline alkaloids: in vivo metabolites of L-dopa in man.

Authors:  M Sandler; S B Carter; K R Hunter; G M Stern
Journal:  Nature       Date:  1973-02-16       Impact factor: 49.962

2.  Alkaloids in mammalian tissues. 2. Synthesis of (+)-and (-)-1-substituted-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines.

Authors:  S Teitel; J O'Brien; A Brossi
Journal:  J Med Chem       Date:  1972-08       Impact factor: 7.446

3.  Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.

Authors:  J Sian; D T Dexter; A J Lees; S Daniel; Y Agid; F Javoy-Agid; P Jenner; C D Marsden
Journal:  Ann Neurol       Date:  1994-09       Impact factor: 10.422

4.  Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.

Authors:  M Naoi; W Maruyama; P Dostert; Y Hashizume; D Nakahara; T Takahashi; M Ota
Journal:  Brain Res       Date:  1996-02-19       Impact factor: 3.252

Review 5.  The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.

Authors:  S Fahn; G Cohen
Journal:  Ann Neurol       Date:  1992-12       Impact factor: 10.422

6.  Naturally-occurring isoquinolines perturb monamine metabolism in the brain: studied by in vivo microdialysis.

Authors:  W Maruyama; D Nakahara; P Dostert; A Takahashi; M Naoi
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 7.  Oxidative mechanisms in nigral cell death in Parkinson's disease.

Authors:  P Jenner
Journal:  Mov Disord       Date:  1998       Impact factor: 10.338

8.  The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis.

Authors:  Hong Qing; Haiyun Xu; Zelan Wei; Kurt Gibson; Xin-Min Li
Journal:  Eur J Neurosci       Date:  2003-04       Impact factor: 3.386

9.  A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in Parkinsonian cerebrospinal fluid.

Authors:  W Maruyama; T Abe; H Tohgi; P Dostert; M Naoi
Journal:  Ann Neurol       Date:  1996-07       Impact factor: 10.422

Review 10.  Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.

Authors:  Makoto Naoi; Wakako Maruyama; Georgy M Nagy
Journal:  Neurotoxicology       Date:  2004-01       Impact factor: 4.294

View more
  4 in total

Review 1.  Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.

Authors:  Isidre Ferrer; Anna Martinez; Rosa Blanco; Ester Dalfó; Margarita Carmona
Journal:  J Neural Transm (Vienna)       Date:  2010-09-23       Impact factor: 3.575

Review 2.  The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease.

Authors:  Zixuan Chen; Madiha Rasheed; Yulin Deng
Journal:  Brain Pathol       Date:  2021-08-20       Impact factor: 7.611

3.  1-Methyl-4-phenyl-pyridinium time-dependently alters expressions of oxoguanine glycosylase 1 and xeroderma pigmentosum group F protein in PC12 cells.

Authors:  Hong-Mei Liu; Shan-Zheng Yang; Feng-Yan Sun
Journal:  Neurosci Bull       Date:  2010-02       Impact factor: 5.203

4.  Oxidative modification of human ceruloplasmin induced by a catechol neurotoxin, salsolinol.

Authors:  Seung-Sub Kim; Jae Yoon Kang; Jung Hoon Kang
Journal:  BMB Rep       Date:  2016-01       Impact factor: 4.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.